CDKN1B and cancer: Interestingly, ascleposide downregulates these Cip/Kip proteins rather than upregulating them150, possibly because p21 and p27 resist the apoptotic response in cancer cells153,154, thus explaining the ascleposide-induced p21 and p27 downregulation, and anticancer activity in CRPC cells150.